Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old)
Clinical trial NCT04550351 · UNKNOWN
Trial details
- NCT number
- NCT04550351
- Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-19
- Primary completion
- 2020-12-18
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.